Skip to main content
Fisher & Paykel Healthcare Corporation Limited (ASX:FPH)
Australia flag Australia · Delayed Price · Currency is AUD
33.92
-0.39 (-1.14%)
Jun 13, 2025, 4:10 PM AEST

ASX:FPH Revenue

In the fiscal year ending March 31, 2025, Fisher & Paykel Healthcare Corporation had annual revenue of 2.02B NZD with 15.96% growth. Fisher & Paykel Healthcare Corporation had revenue of 1.07B in the half year ending March 31, 2025, with 20.13% growth.

Revenue
2.02B NZD
Revenue Growth
+15.96%
P/S Ratio
10.83
Revenue / Employee
271.64K NZD
Employees
7,440
Market Cap
19.90B AUD

Revenue Chart

* This company reports financials in NZD.

History

Fiscal Year End Revenue Change Growth
Mar 31, 20252.02B278.20M15.96%
Mar 31, 20241.74B161.70M10.23%
Mar 31, 20231.58B-100.60M-5.98%
Mar 31, 20221.68B-289.50M-14.69%
Mar 31, 20211.97B707.50M55.99%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CSL Limited 24.61B
Pro Medicus 184.58M
Cochlear 2.31B
Sonic Healthcare 9.33B
Telix Pharmaceuticals 783.21M
Ramsay Health Care 17.12B
Ansell 3.00B
Mesoblast 9.16M
Revenue Rankings

Fisher & Paykel Healthcare Corporation News

More News